Amsterdam, 15 June 2023 – Holland Capital invests in Attenza, a care organization specialized in offering terminal palliative care at home. With the investment Attenza can execute its ambitious growth path.
Palliative terminal care
The aging population in the Netherlands and the increasing number of elderly living at home have led to a higher demand for palliative terminal care at home. Attenza provides this care to patients who wish to spend their last days at home with an intensive need for care. Attenza is able to quickly scale up or down palliative terminal care requests and is up to 24 hours per day available at the patient with a small team of care takers to provide comfort and quality care during the final stage of life. The company uses a proprietary software application, which contributes to the success and self-organization of the team, the quality of care and rapid deployment.
The partnership
Due to the partnership with Holland Capital Attenza can further expand its care services, resulting in nationwide coverage.
Carin van der Kaaden (Director of Attenza): “We are delighted to continue our passion together with Holland Capital. Enabling the highest possible quality of both living and dying at home with a small team of dedicated and well-trained professionals, for patients who have the last wish to pass away at home.”
Margot Engels (Partner Healthcare of Holland Capital): “We are proud to add Attenza to our portfolio of healthcare companies. We look forward to supporting the organization and its management in their growth ambitions.”
Almende has been involved in Attenza as a shareholder since 2017 and has actively supported the establishment and expansion of its proposition.
Jan Peter Larsen, CEO of Almende: “We are proud of the unique concept we have established with Attenza and the impact it has on people’s lives. The arrival of Holland Capital is the next step in Attenza’s ambition to offer this form of care nationwide.”
About Attenza
Attenza, founded in 2015, provides palliative terminal intensive care for individuals with specialized needs. Attenza’s mission is to ensure that everyone can spend their last weeks of their life comfortably at home. This is made possible through the swift and effective deployment of a small team of expert caregivers per patient.
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 160 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare, Technology and Food & Agri. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
About Almende
Almende is a Rotterdam-based venture builder that focuses on self-organization and technological innovation with a significant societal impact. With over 20 years of experience, Almende has created and scaled successful startups and scaleups in the fields of robotics, communication, and healthcare.
Holland Venture start nieuw private equity fonds
Amsterdam, 1 juli 2009 - Holland Venture heeft een nieuw private equity fonds van 70 miljoen euro opgezet dat zich richt op groei- en buy-out investeringen in de Benelux. De doelgroep van het fonds bestaat uit bestaande ondernemingen met een ondernemingswaarde tussen...
Verkoop Orthos Europe BV aan Atrium Innovations Inc.
Amsterdam, 22 september 2008 - Holland Venture heeft vandaag haar meerderheidsbelang in Orthos Europe BV verkocht. Orthos Europe BV houdt 100% van de aandelen van AOV Orthomoleculaire Voedingssupplementen BV, een onderneming die hooggedoseerde voedingssupplementen...
Holland Venture verkoopt haar meerderheidsbelang in Sunday’s International aan het management van de onderneming
Amsterdam, 9 juni 2008 - Holland Venture heeft haar meerderheidsbelang in Sunday’s International verkocht aan het management van de onderneming onder leiding van algemeen directeur Rob Bontje. Holland Venture realiseert hiermee een aantrekkelijk rendement op het...
Holland Venture verkoopt haar aandelen in INS Group S.A.
Amsterdam, 12 september 2007 - Holland Venture is verheugd om u te kunnen melden dat zij haar aandelen in INS Group, een in België gevestigd netwerk and systemen integrator, aan BT verkocht heeft. Met BT is overeengekomen dat zij 100% van de aandelen in INS Group...
Vacature Investment Analyst Healthcare BO
Investment Manager buy-out HealthcareInvestment Manager buy-out Healthcare Sector: Private Equity en Venture Capital Locatie: Amsterdam Opleidingsniveau: WO Over onze organisatie Holland Capital is een succesvolle participatiemaatschappij welke zich richt op...
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei Eindhoven, 25 maart 2019 - CytoSMART, de Eindhovense ontwikkelaar en fabrikant van digitale microscopen voor het monitoren van celkweekprocessen, ontvangt een groeifinanciering van 5,2 miljoen euro....
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl